What does CUSIP 22663K107 represent in this 13F holders report?

CUSIP 22663K107 is the security identifier for CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock in Q1 2021?

78 institutional investors reported CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

CUSIP: 22663K107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 94,401,153
Total 13F shares: 30,730,499
Share change: +307,062
Total reported value: $465,273,247
Price per share: $15.28
Number of holders: 78
Value change: +$5,520,857
Number of buys: 32
Number of sells: 35

Quarterly Holders Quick Answers

What is CUSIP 22663K107?
CUSIP 22663K107 identifies CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 22663K107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5.2%	4,938,349	$69,680,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	3.9%	3,659,381	$51,634,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	2.9%	2,753,567	$38,853,000	—	31 Dec 2020	13F
Vivo Capital, LLC	13F	Company	2.5%	2,335,889	$32,959,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	2.2%	2,113,195	$29,816,000	—	31 Dec 2020	13F
Versant Venture Management, LLC	13F	Company	2.2%	2,030,616	$28,652,000	—	31 Dec 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	1.5%	1,453,966	$20,515,000	—	31 Dec 2020	13F
5AM Venture Management, LLC	13F	Company	1.4%	1,362,286	$19,222,000	—	31 Dec 2020	13F
Point72 Asset Management, L.P.	13F	Company	1.3%	1,225,003	$17,285,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	1.2%	1,152,258	$16,257,000	—	31 Dec 2020	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	1.1%	1,071,428	$15,118,000	—	31 Dec 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.65%	616,520	$8,699,000	—	31 Dec 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.6%	564,102	$7,959,000	—	31 Dec 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.59%	556,635	$7,854,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.51%	480,799	$6,784,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.42%	400,000	$5,644,000	—	31 Dec 2020	13F
Altium Capital Management LLC	13F	Company	0.38%	361,930	$5,107,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.34%	321,501	$4,536,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.34%	317,536	$4,481,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.29%	272,637	$3,848,000	—	31 Dec 2020	13F
Novo Holdings A/S	13F	Company	0.29%	271,378	$3,829,000	—	31 Dec 2020	13F
Burrage Capital Management LLC	13F	Company	0.24%	224,129	$3,162,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.2%	185,742	$2,620,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	150,723	$2,127,000	—	31 Dec 2020	13F
New Leaf Venture Partners, L.L.C.	13F	Company	0.15%	141,000	$1,990,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.15%	137,162	$1,935,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	128,182	$1,809,000	—	31 Dec 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.09%	88,644	$1,251,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.09%	80,902	$1,142,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.08%	78,974	$1,114,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.06%	59,848	$844,000	—	31 Dec 2020	13F
ALPS ADVISORS INC	13F	Company	0.06%	59,437	$839,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.06%	53,911	$761,000	—	31 Dec 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.06%	52,438	$740,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	46,864	$661,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	40,798	$576,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.04%	38,600	$545,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.04%	36,200	$511,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	30,767	$434,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	27,900	$394,000	—	31 Dec 2020	13F
PDT Partners, LLC	13F	Company	0.03%	26,799	$378,000	—	31 Dec 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	25,500	$360,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	24,800	$350,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.03%	23,895	$337,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	23,193	$327,000	—	31 Dec 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	22,600	$319,000	—	31 Dec 2020	13F
VIRTUS ADVISERS, LLC	13F	Company	0.02%	21,487	$303,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.02%	20,471	$289,000	—	31 Dec 2020	13F
HERSHEY TRUST CO	13F	Company	0.02%	19,778	$279,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	19,320	$272,000	—	31 Dec 2020	13F

Institutional Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q1 2021

As of 31 Mar 2021, Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,730,499 shares. The largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Vivo Capital, LLC, BlackRock Inc., Versant Venture Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, 5AM Venture Management, LLC, Point72 Asset Management, L.P., and VANGUARD GROUP INC. This page lists 78 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

Q1 2021 holders

Holder diff

-6

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.